Acta Oncologica

Accelerated partial breast cancer irradiation (APBI)-the future breast cancer radiotherapy?
pp. 485-486(2)
Author: Karlsson, Per

Review of MammoSite brachytherapy: Advantages, disadvantages and clinical outcomes
pp. 487-494(8)
Authors: Bensaleh, Saleh; Bezak, Eva; Borg, Martin

A planning comparison of dose patterns in organs at risk and predicted risk for radiation induced malignancy in the contralateral breast following radiation therapy of primary breast using conventional, IMRT and Volumetric modulated arc treatment techniques
pp. 495-503(9)
Authors: Johansen, Safora; Cozzi, Luca; Olsen, Dag Rune

Improved survival for women with stage I breast cancer in south-east Sweden: A comparison between two time periods before and after increased use of adjuvant systemic therapy
pp. 504-513(10)
Authors: Johansson, Patrik; Fohlin, Helena; Arnesson, Lars-Gunnar; Dufmats, Monika; Nordenskjold, Kerstin; Nordenskjold, Bo; Stål, Olle; Agrup, Måns; Asking, Bengt; Blomkvist, Tord; Bång, Harald; Dabrosin, Charlotta; Einarsson, Eibert; Gustavsson, Rune; Klintenberg, Claes; Linderholm, Barbro; Malmstrom, Annika; Malterling, Rebecka; Sundquist, Marie; Norberg, Bengt; Rundcrantz, Ann; Skoog, Peter; Starkhammar, Hans; Askmalm, Marie Stenmark; Tejler, Goran; Thorstenson, Sten; Vahlin, Susanne; Vitak, Bedrich

Co-expression of estrogen receptor α and Apolipoprotein D in node positive operable breast cancer - possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients
pp. 514-521(8)
Authors: Søiland, Håvard; Skaland, Ivar; Varhaug, Jan Erik; Kørner, Hartwig; Janssen, Emiel; Gudlaugsson, Einar; Baak, Jan; Søreide, Jon Arne

An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer
pp. 522-531(10)
Authors: Henriksen, Katrine; Rasmussen, Birgitte; Lykkesfeldt, Anne; Møller, Susanne; Ejlertsen, Bent; Mouridsen, Henning

Cognitive function and quality of life after surgery for early breast cancer in North Jutland, Denmark
pp. 532-540(9)
Authors: Debess, Jeanne; Riis, Jens Østergaard; Pedersen, Lars; Ewertz, Marianne

Squamous cell carcinoma of the hypopharynx: Single-institution outcome analysis of a large cohort of patients treated with primary non-surgical approaches
pp. 541-548(8)
Authors: Gupta, Tejpal; Chopra, Supriya; Agarwal, Jai Prakash; Laskar, Sarbani-Ghosh; D'cruz, Anil; Shrivastava, Shyam; Dinshaw, Ketayun

Cancer of the parotid gland; long-term follow-up. A single centre experience on recurrence and survival
pp. 549-555(7)
Authors: Cederblad, Lena; Johansson, Silvia; Enblad, Gunilla; Engstrom, Mats; Blomquist, Erik

Half body irradiation of patients with multiple bone metastases: A phase II trial
pp. 556-561(6)
Authors: Berg, Randi; Yilmaz, Mette; Høyer, Morten; Keldsen, Nina; Nielsen, Ole; Ewertz, Marianne

Hypofractionated radiotherapy denoted as the “Christie scheme”: An effective means of palliating patients with head and neck cancers not suitable for curative treatment
pp. 562-570(9)
Authors: Al-mamgani, Abrahim; Tans, Lisa; Van rooij, Peter; Noever, Inge; Baatenburg de jong, Robert; Levendag, Peter

Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy
pp. 571-577(7)
Authors: Ricardi, Umberto; Filippi, Andrea Riccardo; Guarneri, Alessia; Giglioli, Francesca Romana; Mantovani, Cristina; Fiandra, Christian; Anglesio, Silvia; Ragona, Riccardo

Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analysis
pp. 578-583(6)
Authors: Rusthoven, Kyle; Hammerman, Susan; Kavanagh, Brian; Birtwhistle, Michael; Stares, Mark; Camidge, D. Ross

Comparison of predicted and clinical response to radiotherapy: A radiobiology modelling study
pp. 584-590(7)
Authors: Hedman, Mattias; Bjork-Eriksson, Thomas; Mercke, Claes; West, Catharine; Hesselius, Patrick; Brodin, Ola

Quantitative analysis of tumor growth rate and changes in tumor marker level: Specific growth rate versus doubling time
pp. 591-597(7)
Authors: Mehrara, Esmaeil; Forssell-Aronsson, Eva; Ahlman, Håkan; Bernhardt, Peter

Adult T-cell leukemia/lymphoma (ATL) presenting in the skin: Clinical, histological and immunohistochemical features of 52 cases
pp. 598-604(7)
Authors: Bittencourt, Achilea; Barbosa, Helenemarie; Vieira, Maria Das Gracas; Farre, Lourdes

Rare skin cancer: A population-based cancer registry descriptive study of 151 consecutive cases diagnosed between 1980 and 2004.
pp. 605-609(5)
Authors: Riou-Gotta, Marie-Odile; Fournier, Evelyne; Danzon, Arlette; Pelletier, Fabien; Levang, Julien; Mermet, Isabelle; Blanc, Dominique; Humbert, Philippe; Aubin, Francois

In response to 'Behind EUD'
pp. 610-614(5)
Authors: Mavroidis, Panayiotis; Lind, Bengt

Behind [image omitted] : In Response to Drs. Mavroidis and Lind
pp. 614-617(4)
Authors: Wang, Jian; Huang, Zhibin; Mayr, Nina; Yuh, William

Analyzing Toposimerase II-α and HER-2/neu co-amplification seems to be of limited value in epithelial ovarian cancer
pp. 617-619(3)
Authors: Maenpaa, Johanna; Tanner, Minna; Isola, Jorma

Motesanib diphosphate (AMG 706), an oral angiogenesis inhibitor, demonstrates clinical efficacy in advanced thymoma
pp. 619-621(3)
Authors: Azad, Arun; Herbertson, Rebecca; Pook, David; White, Shane; Mitchell, Paul; Tebbutt, Niall

Flare-up: An often unreported phenomenon nevertheless familiar to oncologists prescribing tyrosine kinase inhibitors
pp. 621-624(4)
Authors: Wolter, Pascal; Beuselinck, Benoit; Pans, Steven; Schoffski, Patrick

A suspicion of chikungunya leading to a diagnosis of angioimmunoblastic T-cell lymphoma
pp. 624-628(5)
Authors: Braiteh, Fadi; Parikh, Ankur; McLaughlin, Peter

Lack of somatic mutations in VEGFR-2 tyrosine kinase domain in hepatocellular carcinoma
pp. 628-630(3)
Authors: Chuah, Benjamin; Yeo, Wee-Lee; Guo, Jia Yi; Lim, Seng-Gee; Yap, Hui-Ling; Goh, Boon-Cher; Lee, Soo-Chin

Evolution of glioblastoma
pp. 630-631(2)
Authors: Hofer, Silvia; Kollias, Spyros; Weller, Michael

Fatal drug-drug interaction of brivudine and capecitabine
pp. 631-633(3)
Authors: Ratz Bravo, Alexandra; Hofer, Silvia; Krahenbuhl, Stephan; Ludwig, Christian

Mangafodipir as a cytoprotective adjunct to chemotherapy - a case report
pp. 633-635(3)
Authors: Yri, Olav Erich; Vig, Jens; Hegstad, Elisabeth; Hovde, Øistein; Pignon, Ingrid; Jynge, Per

An unusual presentation of hand-foot syndrome at the hidden area: The scrotum and penis
pp. 636-637(2)
Authors: Lee, Young Joo; Lee, Hee Jung; Jeong, Ki Cheon; Kang, Jung Gu; Lee, Sang Hoon; Kim, Yong Tai

Malignant arrhythmia: A case report of nasal NK/T-cell lymphoma with cardiac involvement
pp. 637-639(3)
Authors: Kanesvaran, Ravindran; Tao, Miriam; Huat, Iain Tan Bee; Weng, Daniel Tan Shao; Eng, David Ng Chee; Thye, Lim Soon